drugset

drugset / Trial / NCT00294944

The Effectiveness of Idazoxan in Treating TRD

NCT00294944 ↗

Phase 3 Withdrawn Sheba Medical Center

RandomizedParallel-groupDouble-blind

Summary

Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Idazoxan	Small molecule	—	—

Indications